Abstract
Purpose
A low albumin level has been reported to be a prognostic factor for various cancers. The aim of this study was to determine the association between preoperative serum albumin level and survival in patients with epithelial ovarian cancer (EOC).
Methods
Records of 337 patients with EOC that underwent optimal cytoreductive surgery were retrospectively reviewed. Threshold albumin level was planned as 32.5 g L−1 due to the statistical analyses.
Results
Mean overall survival was 51.5 months. Area under the ROC curve was found statistically significant for the discriminative role of albumin for survival outcome (AUC = 0.857, 95% CI 0.813–0.90, P < 0.001). The best cut-off point for albumin was determined as 32.5 g L−1. The sensitivity rate, specificity rate, positive and negative predictive values, and accuracy rate for this cut-off level were found 67.2, 91.2, 81.2, 83.1, and 82.5%, respectively. Preoperative hypoalbuminemia was noted in 101 (30.0%) of the patients, of which 6.2% had an albumin level <25 g L−1. The albumin level was independently and significantly associated with overall survival (HR 2.6; 95% CI 2.1–3.1; P < 0.001). Subgroup analysis showed that patients with an albumin level <32.5 and ≥32.5 g L−1 had mean estimated overall survival of 40.6 and 96.0 months, respectively. Age, stage, and presence of ascites were the other independent significant factors.
Conclusions
The preoperative albumin level is an independent prognostic factor for overall survival in optimally debulked EOC patients. Further investigations about preoperative albumin level in prognostic models will contribute to the literature.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Ovarian cancer accounts for the 3.6% of all cancers, with 239,000 new cases and 4.3% of all cancer-related deaths in females annually [1]. Epithelial ovarian cancer (EOC) is the most common histological type of ovarian cancer and the initial treatment includes surgery followed by chemotherapy. It is well known that the surgical outcome directly affects survival [2,3,4,5]. The majority of EOC patients are diagnosed at an advanced stage due to an asymptomatic disease process with non-specific signs and commonly require aggressive surgical treatment.
Advanced-stage disease is frequently associated with ascites, nutritional deficit, weight loss, and poor patient performance. Various parameters, including hemoglobin, total protein, albumin, and transferrin, are used to evaluate nutritional status in patients with gynecological cancers [6]. Albumin is the most abundant plasma protein. It is synthesized in the liver, but is not stored. The rate of albumin synthesis is associated with nutritional and disease states [7], and the albumin level is an objective parameter used to measure malnutrition.
Ovarian cancer is the most common one associated with hypoalbuminemia among gynecological cancers. There are multiple mechanisms to be accused of hypoalbuminemia in ovarian cancer such as: most of the patients are diagnosed at advanced stage that causes decreased motility in the gastrointestinal tract, resulting a worse digestion, reduced appetite, and malnutrition in various levels; ascites causes loss of proteins in the intravascular space; the tumor burden causes a cytokine-related systemic effect resulting a negative nitrogen balance.
Hypoalbuminemia is a risk factor for poor perioperative results in gynecological cancer patients [8,9,10]. Moreover, hypoalbuminemia is associated with survival in patients with such cancers as glioblastoma multiforme [11], gastric cancer [12], breast cancer [13], ovarian cancer [9, 14], endometrial cancer [15], head and neck cancer [16], and non-small cell lung cancer [17]. Based on these findings, the present study aimed to determine the association between the preoperative serum albumin level and survival in patients with EOC that underwent optimal cytoreductive surgery.
Materials and methods
This is a retrospective non-randomized study including a single center experience. EOC patients that underwent primary cytoreductive surgery were retrospectively evaluated. Data were obtained from hospital records, and patients that underwent surgery between 2007 and 2014 were included. Optimally debulked patients were included in the study to minimize the heterogeneity due to the differences in residual tumor volume. Optimal debulking was defined as cytoreductive surgery with residual tumor volume <1 cm [18]. Exclusion criteria were non-optimal surgery (residual tumor volume ≥1 cm), a history of neoadjuvant chemotherapy, incomplete follow-up data, and any disorder affecting the albumin level (such as liver deficiency and nephrotic syndrome). All patients underwent standard surgery, including hysterectomy, bilateral salpingo-oophorectomy, bilateral para-aortic and pelvic lymph node dissection, omentectomy, appendectomy, and peritoneal tumor resection, and extended surgery in cases of metastatic disease. Paclitaxel and platinum-based adjuvant chemotherapy were planned postoperatively [19]. The study included 337 of 401 patients that met the inclusion criteria. Distribution of excluded patients was as follows: residual tumor volume ≥1 cm and interval debulking 51 patients, neoadjuvant chemotherapy for 13 patients. All of these patients had an ASA score of ≥3.
The FIGO (International Federation of Gynecologists and Obstetricians) system was used for disease staging. Disease stage was classified as early (stage I and II) and advanced (stage III and IV). Disease grade was classified as low (G1 and 2) and high (G3 and clear cell).
A surgical complexity score (SCS) was also used for definition of extension of procedures as reported previously [20].
Data were analyzed using SPSS for Windows v.15.0 (SPSS, Inc., Chicago, IL, USA). Categorical variables were compared using the Chi-square test or Fisher’s exact test, as appropriate. Kaplan–Meier and Cox regression analyses were used to analyze survival. Logistic regression analysis was used to evaluate independent samples affecting albumin level. A receiver-operating characteristic (ROC) curve was used to assess the discriminative role of the albumin level and Ca125 level between alive and dead patients. Area under a curve was found significant for both variables. The point at which the sum of specificity and sensitivity reached the maximum was taken as the best cut-off point. Cut-off point for albumin and Ca125 was determined as 32.5 g L−1 and 248.6 IU, respectively. The patients were divided into three subgroups according to the albumin level: <25, 25–34, and ≥35 g L−1. The level of statistical significance was set at P < 0.05.
Results
Study included 337 patients with a mean age of 53.7 ± 11.9 years (range 21–87 years) and 68.8% of the patients were aged <60 years. Mean overall survival was 51.5 ± 24.0 months (range 4–112 months). General patient characteristics are shown in Table 1. The incidence of serous histology, G3 disease, and advanced-stage disease was 73.3, 56.7, and 70.3%, respectively. In all, 237 patients underwent standard surgery and 100 patients underwent extended surgery. Surgical characteristics are summarized in Table 2.
Area under the ROC curve was found statistically significantly for the discriminative role of albumin for survival outcome (AUC = 0.857, 95% CI 0.813–0.90, P < 0.001) (Fig. 1). The best cut-off point for albumin level predicting the survival outcome was determined as 32.5 g L−1. The sensitivity rate, specificity rate, and positive and negative predictive values were found 67.2, 91.2, 81.2, and 83.1%, respectively. The diagnostic accuracy rate was 82.5% at this point.
Preoperative hypoalbuminemia was noted in 101 (30.0%) of the patients and 6.2% of the patients had an albumin level <25 g L−1. According to multivariate analysis, advanced-stage disease (HR 2.4; 95% CI 1.5–3.8; P < 0.001) and ascites (HR 1.4; 95% CI 1.01–1.8; P = 0.04) were independent factors significantly associated with the albumin level. Factors associated with the albumin level based on univariate analysis are shown in Table 3.
Prognostic factors were evaluated via multivariate and univariate analyses, separately. Prognostic factors according to univariate analysis are shown in Table 4. Multivariate analysis of age, histology, disease grade, LVI, para-aortic lymph node involvement (PaLNI), lymph node involvement (LNI), disease stage, the Ca125 level, ascites, and the preoperative albumin level showed that the albumin level was independently and significantly associated with overall survival (HR 2.6; 95% CI 2.1–3.1; P < 0.001). Moreover, in multivariate analysis of patients with advanced-stage disease of age, histology, disease grade, LVI, para-aortic lymph node involvement (PaLNI), lymph node involvement (LNI), the Ca125 level, ascites, and the preoperative albumin level showed that the albumin level was independently and significantly associated with overall survival (HR 2.52; 95% CI 2.06–3.08; P < 0.001). The other significant independent prognostic factors were age, disease stage, and presence of ascites (Table 4). In univariate analyses, patients with an albumin level <32.5 and ≥32.5 g L−1 had mean estimated overall survival of 40.6 and 96.0 months, respectively (P < 0.001). In addition, subgroup analysis according to the albumin level (<25, 25–34, and ≥35 g L−1) showed that mean estimated overall survival was 19.6, 62.2, and 79.1 months, respectively.
Majority of patients had intermediate SCS level. The surgical properties of patients were summarized in Table 2. The most frequent postoperative complications were ileus (20 patients, 6.0%), wound infection (18 patients, 5.4%), and pleural effusion (17 patients, 5.1%). Thirty-two patients (9.5%) needed postoperative intensive care. Moreover, the preoperative albumin level was not associated with the postoperative complication rate or the requirement of intensive care, whereas the presence of ascites was associated with both (P < 0.001 for both) and age was associated with the requirement of intensive care (P = 0.038), according to multivariate analysis.
Discussion
The albumin synthesis and degradation rates and its distribution through the body are determinants of the serum albumin level [7]. Serum albumin level is one of the laboratory measurements that can be used for nutritional status of patients [21, 22]. Normal range of albumin is 3.5–5 g/dL in adults and levels <3.5 g/dL are defined as hypoalbuminemia [23]. Ovarian cancer-related hypoalbuminemia is a result of a decrease in the synthesis of and an increase in leakage of albumin to the extravascular space with ascites. There is a lack of consensus concerning the albumin cut-off level [14, 24].
Cancer patients frequently have lower albumin levels especially in advanced stages. Multiple mechanisms may result in hypoalbuminemia in these patients. Malnutrition, low appetite, and weight loss are common problems. This results in low intake of aminoacids and a negative nitrogen balance and degradation in albumin synthesis. Another factor that decreases the albumin synthesis is inflammation [25]. Increased inflammatory response with the production of cytokines such as interleukin-6 and tumor necrosis factor is detected in cancer patients with lung cancer and various gastrointestinal system cancers [26,27,28]. EOC has an asymptomatic course and the majority of patients have advanced-stage disease at the time of presentation. Advanced-stage disease is usually accompanied by high tumor burden, ascites, weight loss or cachexia, and varying degrees of malnutrition. It was reported that 24% of patients with gynecological cancers are malnourished and those with ovarian cancer have the highest rate of malnutrition (67%) [21].
There is an association between preoperative hypoalbuminemia, and postoperative morbidity and mortality of gynecological and non-gynecological approaches [8, 9, 24, 29, 30]. Moreover, an albumin fall occurs after surgery [31]. In addition to the short-term effects mentioned above, the preoperative albumin level is associated with survival in various cancers. Moreover, a study that included 337 endometrial cancer patients showed there was an association between the pretreatment serum albumin level, and disease-free survival (P = 0.02) and progression-free survival (P < 0.001) [15]. Ovarian cancer is the most common gynecological cancer that occurs concomitantly with hypoalbuminemia. A review about pretreatment albumin levels including 29 studies about various cancers concludes that pretreatment of serum albumin levels provide useful prognostic significance in cancer [32]. There are several studies in the literature evaluating the prognostic value of albumin in ovarian cancer. Asher et al. reported that there is an association between a low albumin level and poor survival in ovarian cancer patients [14]. They also reported that there is an inverse correlation between a low albumin level and median survival. Gupta et al. investigated the role of albumin level with a cutoff of 3.6 g/dL and reported a relative risk of 0.39 for every one g/dL increase (P < 0.001) [33]. A recent study that included 604 EOC patients observed a strong correlation between a low albumin level and median overall survival (P = 0.002, 24 vs. 83 months) [8]. An albumin level of ≥3.7 g/dL was found in association with 40% reduction in mortality risk in over than 80 years ovarian and primary peritoneal cancer patients [34]. Also there are published data about the importance of albumin level using in prognostic models for ovarian cancer [35,36,37,38].
Albumin is the most abundant plasma protein and has a wide range in EOC patients. Advanced-stage patients who were subjected to more aggressive surgical approaches need albumin replacement. Recent studies emphasize the importance of preoperative albumin level in short-term and long-term results. Prospective studies regarding the albumin replacement preoperatively and postoperatively may open new horizons in management of these patients. The use of fresh frozen plasma and total parenteral nutrition, or high-protein diet before and after surgery may be discussed with albumin levels.
The present findings are in agreement with those of earlier studies on the relationship between the preoperative albumin level and survival in patients with various cancers, including ovarian cancer. Optimally debulked patients were included in the study to minimize heterogeneity. Exploration of intraoperative data, standard surgical and medical management of single center, and substantial number of patients for single center are considered as strengths of the study. On the other hand, lack of a clearly defined optimal albumin level and cut-off level for hypoalbuminemia, retrospective design, and lack of power analysis are considered limitations of the present study retrospective.
Conclusion
The present study investigated the relationship between the preoperative albumin level and overall survival in EOC patients, and observed an association between the serum albumin level and overall survival. In addition, disease stage and the Ca125 level were independently associated with overall survival. Moreover, there was not an association between the albumin level and perioperative outcome in the present study, in contrast to earlier studies. Based on the present findings, we think that additional prospective studies on the effect of the preoperative albumin level on survival in patients with gynecological cancers are warranted. Furthermore, the albumin level might be used for preoperative evaluation of patients and can be used in risk prediction models.
References
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210 (Epub 2014 Oct 9)
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol 20:1248–1259
du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische OnkologieStudiengruppeOvarialkarzinom (AGO-OVAR) and the Grouped’InvestigateursNationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 115:1234–1244
Chang SJ, Hodeib M, Chang J, Bristow RE (2013) Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 130(3):493–498. doi:10.1016/j.ygyno.2013.05.040 (Epub 2013 Jun 6)
Bian C, Yao K, Li L, Yi T, Zhao X (2016) Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer. Arch Gynecol Obstet 293(1):163–168. doi:10.1007/s00404-015-3813-z (Epub 2015 Jul 22)
Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A (2007) Malnutrition among gynaecological cancer patients. Eur J Clin Nutr 61(5):642–646 (Epub 2006 Oct 4)
Nicholson JP, Wolmarans MR, Park GR (2000) The role of albumin in critical illness. Br J Anaesth 85(4):599–610
Uppal S, Al-Niaimi A, Rice LW, Rose SL, Kushner DM, Spencer RJ et al (2013) Preoperative hypoalbuminemia is an independent predictor of poor perioperative outcomes in women undergoing open surgery for gynecologic malignancies. Gynecol Oncol 131(2):416–422. doi:10.1016/j.ygyno.2013.08.011 (Epub 2013 Aug 17)
Ataseven B, du Bois A, Reinthaller A, Traut A, Heitz F, Aust S, Prader S et al (2015) Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecol Oncol 138(3):560–565. doi:10.1016/j.ygyno.2015.07.005 (Epub 2015 Jul 8)
Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, McGree ME et al (2016) Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecol Oncol 140(1):15–21. doi:10.1016/j.ygyno.2015.10.025 (Epub 2015 Nov 2)
Schwartzbaum JA, Lal P, Evanoff W, Mamrak S, Yates A, Barnett GH et al (1999) Presurgical serum albumin levels predict survival time from glioblastoma multiforme. J Neurooncol 43(1):35–41
Lien YC, Hsieh CC, Wu YC, Hsu HS, Hsu WH, Wang LS et al (2004) Preoperative serum albumin level is a prognostic indicator for adenocarcinoma of the gastric cardia. J Gastrointest Surg 8(8):1041–1048
Al Murri AM, Bartlett JM, Canney PA, Doughty JC, Wilson C, McMillan DC (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227–230
Asher V, Lee J, Bali A (2012) Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol 29(3):2005–2009. doi:10.1007/s12032-011-0019-5 (Epub 2011 Jul 7)
Seebacher V, Grimm C, Reinthaller A, Heinze G, Tempfer C, Hefler L et al (2013) The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol 171(1):101–106. doi:10.1016/j.ejogrb.2013.07.044 (Epub 2013 Aug 11)
Danan D, Shonka DC Jr, Selman Y, Chow Z, Smolkin ME, Jameson MJ (2016) Prognostic value of albumin in patients with head and neck cancer. Laryngoscope 126(7):1567–1571. doi:10.1002/lary.25877 (Epub 2016 Feb 10)
Fiala O, Pesek M, Finek J, Racek J, Minarik M, Benesova L et al (2016) Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib. Neoplasma 63(3):471–476. doi:10.4149/318_151001N512
Ren Y, Jiang R, Yin S, You C, Liu D, Cheng X, Tang J, Zang R (2015) Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study. BMC Cancer 13(15):583. doi:10.1186/s12885-015-1525-1
Bookman MA, Greer BE, Ozols RF (2003) Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5. Int J Gynecol Cancer 13(6):735–740
Aletti GD, Dowdy SC, Podratz KC et al (2007) Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197:676.e1–676.e7
Laky B, Janda M, Cleghorn G, Obermair A (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87:1678–1685
McIntosh EN, Laurent LL (1983) Nutritional assessment of the hospitalized patient. Am Fam Physician 27:169–175
Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246:1047–1051
Montomoli J, Erichsen R, Antonsen S, Nilsson T, Sørensen HT (2015) Impact of preoperative serum albumin on 30- day mortality following surgery for colorectal cancer: a population-based cohort study. BMJ Open Gastroenterol. 2(1):e000047. doi:10.1136/bmjgast-2015-000047 (eCollection 2015)
Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994) Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 43:697–705
Simons JP, Schols AM, Buurman WA, Wouters EF (1999) Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 97:215–223
O’Gorman P, McMillan DC, McArdle CS (1998) Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32:76–80
Barber MD, Ross JA, Fearon KC (1999) Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35:106–110
Langstraat C, Aletti GD, Cliby WA (2011) Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization. Gynecol Oncol 123(2):187–191. doi:10.1016/j.ygyno.2011.06.031 (Epub 2011 Jul 26)
Kang SC, Kim HI, Kim MG (2016) Low serum albumin level, male sex, and total gastrectomy are risk factors of severe postoperative complications in elderly gastric cancer patients. J Gastric Cancer 16(1):43–50. doi:10.5230/jgc.2016.16.1.43 (Epub 2016 Mar 31)
Fotopoulou C, Jones BP, Savvatis K, Campbell J, Kyrgiou M, Farthing A, Brett S, Roux R, Hall M, Rustin G, Gabra H, Jiao L, Stümpfle R (2016) Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities. Arch Gynecol Obstet 294(3):607–614. doi:10.1007/s00404-016-4080-3 (Epub 2016 Apr 4)
Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiologicalliterature. Nutr J 22(9):69. doi:10.1186/1475-2891-9-69
Gupta D, Lmmersfeld C, Vashi PG, Dahlk S, Grutsch JF, Lis CG (2009) Is serum albumin an independent predictor of survival in ovarian cancer? Clin Ovarian Cancer 2:52–56
Alphs HH, Zahurak ML, Bristow RE, Diaz-Montes TP (2006) Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol 103:1048–1053
Sharma R, Hook J, Kumar M, Gabra H (2008) Evaluation of an inflammation based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44:251–256
Clark TG, Stewart ME, Altman DG, Gabra H, Smyth JF (2001) A prognostic model for ovarian cancer. Br J Cancer 85:944–952
Miao Y, Li S, Yan Q, Li B, Feng Y (2016) Prognostic significance of preoperative prognostic nutritional index in epithelial ovarian cancer patients treated with platinum-based chemotherapy. Oncol Res Treat 39(11):712–719 (Epub 2016 Oct 19)
Zhu J, Wang H, Liu CC, Lu Y, Tang H (2016) The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study. J Cancer Res Clin Oncol 142(11):2339–2345. doi:10.1007/s00432-016-2228-y (Epub 2016 Aug 26)
Author information
Authors and Affiliations
Contributions
EG: project development, data collection and management, data analysis, manuscript writing, and editing. İAK: project development, data collection, manuscript writing, and literature search. NH: data analysis and editing. ÖÖA: project development and data management investigation. PD: manuscript writing and editing, and supervision. AA: project development, data management, data analysis, manuscript editing, and supervision.
Corresponding author
Ethics declarations
Ethics statement
Ethical approval for the present study was not required, as it was retrospectively performed.
Conflict of interest
The authors declare there are no conflicts of interest—financial or otherwise—related to the material presented herein.
Rights and permissions
About this article
Cite this article
Ayhan, A., Günakan, E., Alyazıcı, İ. et al. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet 296, 989–995 (2017). https://doi.org/10.1007/s00404-017-4511-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4511-9